Heart & Vascular Medical Advances

New Treatment Option for Aortic Stenosis: Transcatheter Aortic Valve Implantation (TAVR)

Emory Structural Heart ProgramSummary: Emory University Hospital is the first in the Southeast, to study transcatheter aortic valve implantation, a minimally invasive option to treat aortic stenosis. This investigational procedure is easier on patients and offers substantially shorter recovery times than traditional surgery and provides doctors with a new option to treat patients who are too ill or frail to endure traditional open-heart surgery.

Heart Transplant after LVAD

Heart TransplantSummary: The Emory Center for Heart Transplantation in Atlanta, Georgia ranks among the nation's top heart transplant hospitals. At Emory, we perform 25-30 transplants per year. In addition, Emory heart surgeons now offer patients the LVAD (Left Ventricular Assist Device) as both long-terms therapy and as a bridge to transplant.




Emory Adult Congenital Heart Center

Emory Adult Congenital Heart CenterSummary: The EACH Center is one of a few programs of its kind in the U.S. – and the only one in Georgia – specializing in diagnosis and treatment of adults with moderate and complex congenital heart defects (CHDs). The program features a multidisciplinary management team that diagnoses adult patients with CHDs and provides the best care available.


Hybrid Coronary Revascularization

Hybrid Coronary RevascularizationSummary: Hybrid Revascularization combines minimally invasive off – pump left internal mammary artery graft with percutaneous coronary intervention (PCI). The procedure is a “best of both world’s strategy” and allows physicians to work together to tailor a treatment option right for each individual patient.



Novel Treatment for Heart Failure: Ventricular Assist Devices

VADSummary: A ventricular assist device (VAD) is a battery-operated mechanical pump that helps a weakened heart pump blood throughout the body. Emory has started using VADs as an alternative to transplantation (“destination therapy”), when a donor heart is either not available or when a patient is ineligible for/or unwilling to undergo transplantation.